Report Detail

Medical Devices & Consumables Global Digital Biomarker Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4529363
  • |
  • 20 April, 2023
  • |
  • Global
  • |
  • 110 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
According to our (Global Info Research) latest study, the global Digital Biomarker market size was valued at USD 398.5 million in 2022 and is forecast to a readjusted size of USD 23440 million by 2029 with a CAGR of 79.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
This report is a detailed and comprehensive analysis for global Digital Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Digital Biomarker market size and forecasts, in consumption value ($ Million), 2018-2029
Global Digital Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Digital Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Digital Biomarker market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Biomarker market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Philips, Johnson & Johnson, Pfizer, GE Healthcare and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Digital Biomarker market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Passive Digital Biomarker
Active Digital Biomarker
Market segment by Application
Clinical Disease
Daily Health
Market segment by players, this report covers
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Biomarker, with revenue, gross margin and global market share of Digital Biomarker from 2018 to 2023.
Chapter 3, the Digital Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Digital Biomarker market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Biomarker.
Chapter 13, to describe Digital Biomarker research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Digital Biomarker
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Digital Biomarker by Type
    • 1.3.1 Overview: Global Digital Biomarker Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Digital Biomarker Consumption Value Market Share by Type in 2022
    • 1.3.3 Passive Digital Biomarker
    • 1.3.4 Active Digital Biomarker
  • 1.4 Global Digital Biomarker Market by Application
    • 1.4.1 Overview: Global Digital Biomarker Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Clinical Disease
    • 1.4.3 Daily Health
  • 1.5 Global Digital Biomarker Market Size & Forecast
  • 1.6 Global Digital Biomarker Market Size and Forecast by Region
    • 1.6.1 Global Digital Biomarker Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Digital Biomarker Market Size by Region, (2018-2029)
    • 1.6.3 North America Digital Biomarker Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Digital Biomarker Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Digital Biomarker Market Size and Prospect (2018-2029)
    • 1.6.6 South America Digital Biomarker Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Digital Biomarker Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Philips
    • 2.1.1 Philips Details
    • 2.1.2 Philips Major Business
    • 2.1.3 Philips Digital Biomarker Product and Solutions
    • 2.1.4 Philips Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Philips Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Digital Biomarker Product and Solutions
    • 2.2.4 Johnson & Johnson Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Digital Biomarker Product and Solutions
    • 2.3.4 Pfizer Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 GE Healthcare
    • 2.4.1 GE Healthcare Details
    • 2.4.2 GE Healthcare Major Business
    • 2.4.3 GE Healthcare Digital Biomarker Product and Solutions
    • 2.4.4 GE Healthcare Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 GE Healthcare Recent Developments and Future Plans
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Digital Biomarker Product and Solutions
    • 2.5.4 Novartis Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novartis Recent Developments and Future Plans
  • 2.6 Apple
    • 2.6.1 Apple Details
    • 2.6.2 Apple Major Business
    • 2.6.3 Apple Digital Biomarker Product and Solutions
    • 2.6.4 Apple Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Apple Recent Developments and Future Plans
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Digital Biomarker Product and Solutions
    • 2.7.4 Sanofi Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sanofi Recent Developments and Future Plans
  • 2.8 GlaxoSmithKline
    • 2.8.1 GlaxoSmithKline Details
    • 2.8.2 GlaxoSmithKline Major Business
    • 2.8.3 GlaxoSmithKline Digital Biomarker Product and Solutions
    • 2.8.4 GlaxoSmithKline Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Digital Biomarker Product and Solutions
    • 2.9.4 Bayer Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Bayer Recent Developments and Future Plans
  • 2.10 Merck
    • 2.10.1 Merck Details
    • 2.10.2 Merck Major Business
    • 2.10.3 Merck Digital Biomarker Product and Solutions
    • 2.10.4 Merck Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Merck Recent Developments and Future Plans
  • 2.11 Abbott Laboratories
    • 2.11.1 Abbott Laboratories Details
    • 2.11.2 Abbott Laboratories Major Business
    • 2.11.3 Abbott Laboratories Digital Biomarker Product and Solutions
    • 2.11.4 Abbott Laboratories Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.12 Asahi Kasei
    • 2.12.1 Asahi Kasei Details
    • 2.12.2 Asahi Kasei Major Business
    • 2.12.3 Asahi Kasei Digital Biomarker Product and Solutions
    • 2.12.4 Asahi Kasei Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Asahi Kasei Recent Developments and Future Plans
  • 2.13 Biogen
    • 2.13.1 Biogen Details
    • 2.13.2 Biogen Major Business
    • 2.13.3 Biogen Digital Biomarker Product and Solutions
    • 2.13.4 Biogen Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Biogen Recent Developments and Future Plans
  • 2.14 Koneksa Health
    • 2.14.1 Koneksa Health Details
    • 2.14.2 Koneksa Health Major Business
    • 2.14.3 Koneksa Health Digital Biomarker Product and Solutions
    • 2.14.4 Koneksa Health Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Koneksa Health Recent Developments and Future Plans
  • 2.15 Roche
    • 2.15.1 Roche Details
    • 2.15.2 Roche Major Business
    • 2.15.3 Roche Digital Biomarker Product and Solutions
    • 2.15.4 Roche Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Roche Recent Developments and Future Plans
  • 2.16 Huma Therapeutics
    • 2.16.1 Huma Therapeutics Details
    • 2.16.2 Huma Therapeutics Major Business
    • 2.16.3 Huma Therapeutics Digital Biomarker Product and Solutions
    • 2.16.4 Huma Therapeutics Digital Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Huma Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Digital Biomarker Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Digital Biomarker by Company Revenue
    • 3.2.2 Top 3 Digital Biomarker Players Market Share in 2022
    • 3.2.3 Top 6 Digital Biomarker Players Market Share in 2022
  • 3.3 Digital Biomarker Market: Overall Company Footprint Analysis
    • 3.3.1 Digital Biomarker Market: Region Footprint
    • 3.3.2 Digital Biomarker Market: Company Product Type Footprint
    • 3.3.3 Digital Biomarker Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Digital Biomarker Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Digital Biomarker Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Digital Biomarker Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Digital Biomarker Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Digital Biomarker Consumption Value by Type (2018-2029)
  • 6.2 North America Digital Biomarker Consumption Value by Application (2018-2029)
  • 6.3 North America Digital Biomarker Market Size by Country
    • 6.3.1 North America Digital Biomarker Consumption Value by Country (2018-2029)
    • 6.3.2 United States Digital Biomarker Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Digital Biomarker Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Digital Biomarker Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Digital Biomarker Consumption Value by Type (2018-2029)
  • 7.2 Europe Digital Biomarker Consumption Value by Application (2018-2029)
  • 7.3 Europe Digital Biomarker Market Size by Country
    • 7.3.1 Europe Digital Biomarker Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Digital Biomarker Market Size and Forecast (2018-2029)
    • 7.3.3 France Digital Biomarker Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Digital Biomarker Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Digital Biomarker Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Digital Biomarker Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Digital Biomarker Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Digital Biomarker Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Digital Biomarker Market Size by Region
    • 8.3.1 Asia-Pacific Digital Biomarker Consumption Value by Region (2018-2029)
    • 8.3.2 China Digital Biomarker Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Digital Biomarker Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Digital Biomarker Market Size and Forecast (2018-2029)
    • 8.3.5 India Digital Biomarker Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Digital Biomarker Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Digital Biomarker Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Digital Biomarker Consumption Value by Type (2018-2029)
  • 9.2 South America Digital Biomarker Consumption Value by Application (2018-2029)
  • 9.3 South America Digital Biomarker Market Size by Country
    • 9.3.1 South America Digital Biomarker Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Digital Biomarker Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Digital Biomarker Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Digital Biomarker Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Digital Biomarker Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Digital Biomarker Market Size by Country
    • 10.3.1 Middle East & Africa Digital Biomarker Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Digital Biomarker Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Digital Biomarker Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Digital Biomarker Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Digital Biomarker Market Drivers
  • 11.2 Digital Biomarker Market Restraints
  • 11.3 Digital Biomarker Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Digital Biomarker Industry Chain
  • 12.2 Digital Biomarker Upstream Analysis
  • 12.3 Digital Biomarker Midstream Analysis
  • 12.4 Digital Biomarker Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Digital Biomarker. Industry analysis & Market Report on Digital Biomarker is a syndicated market report, published as Global Digital Biomarker Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Digital Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,794.44
    4,191.66
    5,588.88
    3,253.80
    4,880.70
    6,507.60
    539,852.40
    809,778.60
    1,079,704.80
    290,058.00
    435,087.00
    580,116.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report